Related Experiment Videos
[Disorders of gonadal function in hypothalamic-pituitary diseases]
K Tanaka1, M Toriumi, Y Shinohara
1Third Department of Medicine, Teikyo University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 13, 1997
Summary
Secondary hypogonadism, caused by hypothalamic or pituitary issues, requires specific diagnostic criteria and targeted treatments. Understanding its causes, like tumors or Sheehan's syndrome, is key for effective management.
Area of Science:
- Endocrinology
- Reproductive Medicine
Context:
- The hypothalamic-pituitary-gonadal (HPG) axis is crucial for reproductive health, regulated by hormones like GnRH, LH, FSH, and gonadal steroids.
- Secondary hypogonadism arises from disruptions in the hypothalamus or pituitary gland, distinct from primary gonadal dysfunction.
Purpose:
- To detail the etiology, diagnostic approaches, and therapeutic strategies for secondary hypogonadism.
- To provide a comprehensive overview of conditions affecting the HPG axis.
Summary:
- Secondary hypogonadism stems from hypothalamic or pituitary lesions; common causes include hypothalamic germinomas and pituitary tumors or Sheehan's syndrome.
- Diagnosis relies on established criteria, incorporating clinical signs, symptoms, and laboratory tests like serum gonadotropin, sex steroid levels, and LHRH tests.
- Treatment for hypothalamic hypogonadism involves pulsatile GnRH therapy, while pituitary hypogonadism management includes hormone replacement with hCG, hMG, estrogen, or testosterone.
Impact:
- This review aids clinicians in accurately diagnosing and managing secondary hypogonadism, improving patient outcomes.
- Enhances understanding of HPG axis disorders and their clinical implications.